Conservest Capital Advisors Inc. Sells 2,910 Shares of SPDR S&P Biotech ETF $XBI

Conservest Capital Advisors Inc. reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.2% in the second quarter, Holdings Channel reports. The fund owned 28,664 shares of the exchange traded fund’s stock after selling 2,910 shares during the quarter. Conservest Capital Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,377,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. DHJJ Financial Advisors Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $25,000. Garrison Bradford & Associates Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $39,000. Compass Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares during the period. Golden State Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares during the period. Finally, Avalon Trust Co bought a new position in SPDR S&P Biotech ETF in the 1st quarter worth approximately $57,000.

SPDR S&P Biotech ETF Trading Up 0.8%

XBI opened at $108.39 on Friday. The company has a 50 day moving average of $98.08 and a 200 day moving average of $87.88. The company has a market cap of $6.65 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $110.96.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.